Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Preclinical and clinical studies of immunotherapy for the treatment of cholangiocarcinoma

JHEP Reports(2023)10.1016/j.jhepr.2023.100723Source: DataRank Database

Preclinical and clinical studies of immunotherapy for the treatment of cholangiocarcinoma is a research paper published in JHEP Reports (2023). On theSindex it has a DataRank of 0. It has been cited 10 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access10 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 2.54)OA: goldTopics (23)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Benjamin L. Green ORCID,Changqing Xie ORCID,Chao Liu ORCID,Xin Chen ORCID,Xinjun Lu ORCID

Live enrichment

PubMed:37229173 PMC:PMC10205436 OpenAlex:https://openalex.org/W4323667192

National Natural Science Foundation of China

Grant: 82202981

China Postdoctoral Science Foundation

Grant: 2022TQ0386

National Institutes of Health

Grant: R01CA239251

National Institutes of Health

Grant: 5R01CA239251-02

Signaling pathways during hepatocarcinogenesis

European Commission

Grant: 239251

Structural studies of peroxisomal machinery

University of Hawai'i at Mānoa

FWCI

2.54

Citation Percentile

0.9%

Citation Trend

2023

2024

2025

goldLicense: CC BY NC ND

journalhttps://doi.org/10.1016/j.jhepr.2023.100723

publisherhttps://doi.org/10.1016/j.jhepr.2023.100723

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37229173

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10205436

repositoryhttps://doaj.org/article/adf3c5851acb482e828fd1ba1cf07eb5

Fields of Study

Cholangiocarcinoma and Gallbladder Cancer StudiesPeptidase Inhibition and AnalysisCancer Immunotherapy and Biomarkers03 medical and health sciences0302 clinical medicine

Keywords

ImmunotherapyMedicineImmune systemClinical trialCancerTumor microenvironmentCancer immunotherapyMicrosatellite instabilityOncologyBioinformaticsImmunologyInternal medicineBiologyCholangiocarcinomaCombination therapyImmune Checkpoint InhibitorsTumour Immune MicroenvironmentReview

Sustainable Development Goals

SDG 0: Good health and well-being

Preclinical and clinical studies of immunotherapy for the treatment of cholangiocarcinoma

FAIR Checklist

Authors (5)

Funding (6 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)